Charles Silberstein

Charles Silberstein

Plus aucun poste en cours
56 ans
Finance
Consumer Services
Health Technology

Profil

Charles Silberstein is the founder of FytonBio.
Dr. Silberstein is currently an Independent Director at Launchpad Streetlight Acquisition Corp.
Formerly, Dr. Silberstein was Chief Financial Officer at GentiBio, Inc. from 2022 to 2024, CFO & Head of Business Development at Applied Therapeutics, Inc. from 2020 to 2022, Senior Vice President of Business Development at Allergan UC from 2018 to 2020, Vice President at The Boston Company Asset Management LLC from 2006 to 2010, Vice President at Goldman Sachs Asset Management LP from 2000 to 2005, and held Vice President roles at BNY Mellon Investment Adviser, Inc. and Goldman Sachs & Co. LLC.
Education includes an undergraduate degree from Yeshiva University in 1995, a doctorate from Albert Einstein College of Medicine, Inc. in 1995, and an MBA from Columbia Business School in 2000.

Postes actifs de Charles Silberstein

SociétésPosteDébut

Anciens postes connus de Charles Silberstein

SociétésPosteFin
Directeur Financier/CFO 01/01/2024
APPLIED THERAPEUTICS, INC. Directeur Financier/CFO 28/01/2022
ALLERGAN PLC Corporate Officer/Principal 01/05/2020
Gestionnaire de Portefeuille-Actions 01/12/2014
Gestionnaire de Portefeuille-Actions 31/12/2005
Voir l'expérience en détail de Charles Silberstein

Formation de Charles Silberstein

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

97

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Finance

Finance

Finance

Finance

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Charles Silberstein
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇